Evidence map›Paper›PMID 34210566›Full record

SynthesisJournal of substance abuse treatment2022

Contingency management for treatment attendance: A meta-analysis.

Rory A Pfund, Meredith K Ginley, Carla J Rash, Kristyn Zajac

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Journal of substance abuse treatment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Rory A PfundCenter on Alcohol, Substance use, and Addictions, 2650 Yale Blvd SE, Albuquerque, NM 87106, United States of America. Electronic address: rorypfund@gmail.com.
Meredith K GinleyDepartment of Psychology, East Tennessee State University, 420 Rogers Stout Hall, P.O. Box 70649, Johnson City, TN 37614, United States of America.
Carla J RashUniversity of Connecticut School of Medicine, 263 Farmington Avenue (MC 3944), Farmington, CT 06030, United States of America.
Kristyn ZajacUniversity of Connecticut School of Medicine, 263 Farmington Avenue (MC 3944), Farmington, CT 06030, United States of America.
University of Connecticut · USEast Tennessee State University · USNew York State Office of Alcoholism and Substance Abuse Services · US

Funding

Pilot StudiesP50AA027055 · NIAAA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI COVAULT, JONATHAN M · 2019 to 2023
$7.8M
Alcohol Research Training: Methods & MechanismsT32AA018108 · NIAAA · UNIVERSITY OF NEW MEXICO · PI Katie A Witkiewitz · 2010 to 2026
$5.6M
Promoting employment in persons living with HIV/AIDSR01DA047183 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI RASH, CARLA J · 2019 to 2024
$3.4M
Interventions for Unemployed Hazardous DrinkersR01AA023502 · NIAAA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ALESSI, SHEILA MARIE, RASH, CARLA J · 2015 to 2019
$3.1M
A Reinforcement Intervention for Increasing HIV Testing Among At-Risk WomenR01MD013550 · NIMHD · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ZAJAC, KRISTYN · 2018 to 2022
$2.8M
Treating Co-Occurring PTSD and Substance Abuse in High-Risk Transition Age YouthK23DA034879 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ZAJAC, KRISTYN · 2014 to 2018
$964k
NIAAA NIH HHS P50 AA027055NIAAA NIH HHS R01 AA023502NIAAA NIH HHS T32 AA018108NIDA NIH HHS K23 DA034879NIDA NIH HHS R01 DA047183NIMHD NIH HHS R01 MD013550
6 · The paper itself

Abstract

backgroundTreatment providers have applied contingency management (CM) treatment, an intervention that often rewards individuals for drug abstinence (i.e., ABS CM), to treatment engagement as well. However, we know little about the magnitude of treatment effects when providers target attendance behaviors (i.e., ATT CM).

methodsThis study conducted a systematic search to identify studies that included ATT CM, either in isolation or in combination with ABS CM. The study used meta-analysis to estimate the effect size of ATT CM and ABS CM + ATT CM on treatment attendance and drug abstinence. We identified a total of 10 studies including 12 CM treatments (6 ATT CM and 6 ABS CM + ATT CM) with 1841 participants.

resultsResults indicated a moderate effect (d = 0.47, 95% confidence interval (CI) [0.25, 0.69]) of ATT CM on attendance relative to non-reward active comparison conditions. Frequency of rewards was significantly associated with larger effect sizes. Results also indicated a small effect (d = 0.22, 95% CI [0.12, 0.33]) of ATT CM on abstinence outcomes relative to nonreward comparisons, p < 0.001. The study found no significant differences in attendance or abstinence between ATT CM and ABS CM + ATT CM (p's > 0.05).

conclusionOverall, the results supported ATT CM for increasing treatment engagement, with smaller effects on abstinence. Effects on abstinence were smaller than those observed in prior meta-analyses focused on ABS CM. No significant differences existed in attendance or abstinence outcomes between ATT CM and ABS + ATT CM. However, future studies are needed to experimentally compare ABS CM + ATT CM to ABS CM, and ATT CM to determine additive effects. Clinics implementing CM should consider the differential effects between ATT CM and ABS CM when selecting target behavior(s).

Indexed as

Behavior TherapyRewardHumansAbstinenceAttendanceDrug useMotivational incentivesTreatment engagement

Identifiers

PMID34210566
PMCPMC8702584
OpenAlexW3174182003

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.